06.04.2014 Views

Regula+e - General Pharmaceutical Council

Regula+e - General Pharmaceutical Council

Regula+e - General Pharmaceutical Council

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Registrant update<br />

Update on<br />

dispensing<br />

errors<br />

A proposed amendment to the Health<br />

and Social Care Bill seeking a due diligence<br />

defence in the event of a dispensing error<br />

was withdrawn as the Bill made its way<br />

through the final stages of debate in the<br />

House of Lords.<br />

Liberal Democrat peer, Lord Tim Clement-<br />

Jones, had sought an amendment to the<br />

effect that anyone at risk of prosecution<br />

under section 67 of the Medicines Act<br />

would be able to mount a defence that<br />

they had exercised all due diligence to<br />

avoid committing such an offence.<br />

Speaking in the Lords on the withdrawal<br />

of this amendment, Health Minister in the<br />

Lords, Lord Howe, said;<br />

“The Medicines and Healthcare products<br />

Regulatory Agency (MHRA) intends to<br />

carry out a review of sanctions and<br />

penalties in medicines legislation. This will<br />

extend well beyond issues that have<br />

arisen in dispensing errors, but the review<br />

will look at the respective roles of<br />

medicines legislation and professional<br />

regulation in this area.<br />

“The possible role of a due diligence<br />

defence will remain on the table for<br />

consideration in the wider context of this<br />

review. It is worth stressing this point as<br />

due diligence defences have a well<br />

established usage in association with strict<br />

liability offences in many areas of<br />

legislation, including medicines legislation.<br />

“This will be a significant and wideranging<br />

review, and it is important to<br />

ensure that it covers the right ground. The<br />

MHRA would aim to scope the coverage,<br />

conduct and timetable of the review by<br />

September 2012.”<br />

Chief Executive and Registrar,<br />

Duncan Rudkin, said:<br />

“Our view remains that single dispensing<br />

errors, without other significant<br />

aggravating factors, will not amount to a<br />

fitness to practise concern.”<br />

Planning for<br />

the London<br />

Olympics<br />

As part of our planning for the<br />

London Olympics, we have reviewed<br />

the logistics of holding our fitness to<br />

practise hearings In London and at<br />

other locations. We have decided<br />

that from 26 July to 7 September,<br />

our hearings will be held at:<br />

Maple House (first floor)<br />

150 Corporation Street<br />

Birmingham B4 6TB<br />

We will ensure that registrants,<br />

witnesses, advocates, and others<br />

affected by this move are made aware<br />

of this change of location.<br />

The London Olympics will bring an<br />

influx of visitors, staff, and athletes to<br />

Great Britain. Resources to assist with<br />

planning and business continuity<br />

include the Royal <strong>Pharmaceutical</strong><br />

Society’s dedicated webpage at<br />

http://www.rpharms.com/<br />

your-day-to-day-practice/pharmacyand-the-olympics.asp<br />

4 <strong>Regula+e</strong>: March 2012 | Issue 4

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!